STRA vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

STRA

38.1
AI Score
VS
UTI Wins

UTI

38.8
AI Score

Investment Advisor Scores

STRA

38score
Recommendation
AVOID NEW MONEY

UTI

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric STRA UTI Winner
Forward P/E 6.3816 26.5957 STRA
PEG Ratio 0.4254 1.7716 STRA
Revenue Growth 1.6% 7.2% UTI
Earnings Growth 24.8% -78.9% STRA
Tradestie Score 38.1/100 38.8/100 UTI
Profit Margin 0.7% 3.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

STRA 1M: -33.7% · 3M: -33.8% UTI 1M: +11.3% · 3M: -11.0%

Current Technical Phase

STRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.1%), weak momentum, RSI 20

RSI (14): 20.1 · Price: $54.30

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.8 · Price: $23.00

Fundamentals Snapshot

Metric STRA UTI
Market Cap — —
Forward P/E 9.3 31.3
Trailing P/E 170.6 38.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.2% 0.0%
EPS 0.32 0.61
Dividend Yield 0.05% —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.